Article
The need for a commercial test using the penA60 allele to identify ceftriaxone-resistant Neisseria gonorrhoeae.
The Lancet. Infectious diseases - 1 Sept 2022
Tickner Jacob A, Lahra Monica M, Whiley David M
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
